The introduction of CGM in 1999 completely shifted the trajectory of care for people with diabetes. Now, new data suggest advanced CGM metrics, such as time in range, are proving comparable to HbA1c for predicting diabetic retinopathy and other microvascular outcomes.

In this episode, Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes.

00:05 - Intro

02:04 - CGM Data to Predict Diabetes Complications

05:15 - Time in Range and Microvascular Complications

09:36 - Glycemic Variability and Incident Diabetic Retinopathy

12:17 - Time in Range, CGM Data for Predicting CV Outcomes